Antimicrobial Agents and Chemotherapy · 1982 · 74 citations · 17 references
PharmacyClinical PharmacokineticsPharmacokineticsAntimicrobial PharmacotherapyPediatric Clinical PharmacologyPediatric Infectious DiseasesAntimicrobial DosingMultiple-dose PharmacokineticsPediatric Antibiotic TherapyPediatric Antimicrobial TherapyPediatric Drug DosingPharmacokinetics Of AntimicrobialsAntimicrobial Pharmacokinetics In PediatricsBacterial Meningitis TreatmentCeftriaxone TherapyCerebrospinal Fluid DistributionDrug Elimination Half-lifeMeningitis Antibiotic TherapyPlasma Concentration - Time ProfileTrough Concentrations
Single-dose pharmacokinetics of ceftriaxone were determined in 19 patients with proven bacterial meningitis. The dosage was 50 mg of ceftriaxone per kg. The plasma concentration time curve declined in a biexponential manner. The mean peak plasma concentration was 207 micrograms/ml, and the elimination half-life was 4 h. In 12 patients, multiple-dose pharmacokinetics were determined after a loading dose of 75 mg of ceftriaxone per kg, followed by 50-mg/kg doses every 8 h in 5 patients or every 12 h in 7 patients. The mean peak plasma concentration was 230 micrograms/ml after the first dose and 263 micrograms/ml after the last dose. Of 12 patients, 5 had trough values that were larger after multiple doses than after a single dose. Mean penetration of ceftriaxone into cerebrospinal fluid was 3.1%. The median cerebrospinal fluid bactericidal titer against the patients pathogens was greater than 1:1,024 and less than 1:2,048. The drug was well tolerated without adverse effects.
17
David Hansman, Monica M. Bullen · The Lancet · 1967 · 501 citations
David J. Greenblatt, Jan Koch‐Weser · New England Journal of Medicine · 1975 · 434 citations
Microbioassay of Antimicrobial Agents
Harold J. Simon, Elaine Jong Yin · Applied Microbiology · 1970 · 198 citations · Full text